newsfilter
← Latest News
PR Newswire·

PDL BioPharma Responds to Letter from Engine Capital

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today announced that Harold E. Selick, Ph.D., Chairman of the Board of Directors of PDL...